The New Reality Of Hospital-Payer Contracts: How Baptist Health Negotiated With Florida Blue
The contract negotiation process between providers and payers is now more complex than ever, according to Baptist Health CEO Michael Mayo.
Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees To Acquisition By Private Equity
Carlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird Bio for about $29 million. Meanwhile, Pfizer continued the culling of its gene therapies with the discontinuation of Beqvez for hemophilia B.
AI Built for Litigation. Verified by Design.
Grounded in authoritative content and verified at every step, Protégé is the only legal AI tool that delivers work you can trust—without exception.
‘The Hardest Thing Is Separating The Wheat From The Chaff’: 5 Leaders On The State Of Healthcare AI
Healthcare AI is developing at a rapid rate, and the industry’s attitude on how to best regulate and deploy this technology is evolving every day.
What Sets 2025’s Digital Health Funding Environment Apart From Previous Years?
This year, venture capitalists in the digital health landscape have many more quality investment opportunities than they did in the past couple years.
Which Issues Do Healthcare Leaders Want RFK Jr. To Address?
The Senate confirmed Robert F. Kennedy Jr. as secretary of the Department of Health and Human Services. Healthcare leaders hope he addresses issues relating to health coverage, drug costs, and more.
AI Is Reshaping Legal Practice—But Tools Aren’t The Real Differentiator.
Explore the mindset, cultural shifts, and training strategies that define the AI‑savvy lawyer, revealing why human judgment, standardized competence, and integrated learning—not technology alone—will shape the future of the profession.
Senators Introduce Bill That Would Add Work Requirements For Medicaid
Senators John Kennedy (R-Louisiana) and Eric Schmitt (R-Missouri) introduced a bill last week that would require ‘able-bodied adults’ without dependents to work or volunteer for at least 20 hours per week to receive Medicaid benefits.
Could The Trump Administration Change The Medicare Drug Price Negotiation Program?
CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the door open for potential changes. Experts weighed in on what changes could be made and what changes they would like to see.
‘Precision Med Has Evolved As Badly As I Expected’ And Other Takeaways From Former FDA Commissioner At PMWC
Robert Califf addressed a range of issues, including AI, lack of nutrition resources at the FDA, and how he evaluates the progress of precision medicine at the Precision Medicine World Conference in Silicon Valley.
Why Telehealth Advocates Are Calling On The Trump Administration To Withdraw New Telemedicine Rules
The DEA recently released three rules regarding the remote prescribing of controlled substances. However, many telehealth advocates argue that two of these rules hinder access to care.
Filevine’s New Legal AI Platform LOIS Turns AI Into A True Legal Coworker
Legal work isn’t slowing down, and the firms that win won’t be the ones working harder — they’ll be the ones working smarter.
DeepSeek v. ChatGPT: Why Is Healthcare So Expensive In America?
The AI race heats up with a new kid on the block from China. How did it compare against a popular U.S. genAI engine on a simple healthcare industry question?
Are ICHRAs Actually Good For Employers And Employees?
ICHRAs are gaining a lot of interest in healthcare. Some say they are beneficial because they give employees more choice in their health insurance, while others are more skeptical.
Battling Ransomware: How Healthcare Organizations Can Strengthen Cybersecurity To Protect Patient Data
Recognizing its vulnerability to cybercrime, the healthcare industry continues to prioritize cybersecurity. Here are some areas where organizations should be focusing their efforts.
Cybersecurity Threats Continue To Rise For Healthcare Organizations, Research Shows
The vast majority of healthcare organizations have spotted a cyberattack and suffered financial consequences as a result in the past 12 months, according to new research. A separate report also found that overall cyberattacks on healthcare organizations have risen by 32% year-over-year.
VC Firm Foresite Capital Dishes On Biotech Innovation In China, Opportunities In Immunology
China has become a key piece of Foresite Capital’s investment and company formation strategy. During the J.P. Morgan Healthcare Conference, Managing Director Michael Rome shared his thoughts on why biotech in China is booming as well as therapeutic areas where he sees promising science.